about
Genetic deletion of SEPT7 reveals a cell type-specific role of septins in microtubule destabilization for the completion of cytokinesisRecombinase-mediated cassette exchange (RMCE): traditional concepts and current challengesImproved bi-allelic modification of a transcriptionally silent locus in patient-derived iPSC by Cas9 nickaseProtein transduction from retroviral Gag precursorsGammaretroviral vectors: biology, technology and applicationAvoiding cytotoxicity of transposases by dose-controlled mRNA deliveryRetrovirus vectors: toward the plentivirus?Cellular restriction of retrovirus particle-mediated mRNA transfer.In Vivo Killing Capacity of Cytotoxic T Cells Is Limited and Involves Dynamic Interactions and T Cell Cooperativity.Bromo- and extraterminal domain chromatin regulators serve as cofactors for murine leukemia virus integration.Viral and non-viral approaches for transient delivery of mRNA and proteins.Non-integrating gamma-retroviral vectors as a versatile tool for transient zinc-finger nuclease delivery.Potent and reversible lentiviral vector restriction in murine induced pluripotent stem cells.Viral and Synthetic RNA Vector Technologies and Applications.Retrovirus-based mRNA transfer for transient cell manipulation.Pseudotype-independent nonspecific uptake of gammaretroviral and lentiviral particles in human cells.Development of novel efficient SIN vectors with improved safety features for Wiskott-Aldrich syndrome stem cell based gene therapy.Retroviral and transposon-based tet-regulated all-in-one vectors with reduced background expression and improved dynamic range.Self-inactivating alpharetroviral vectors with a split-packaging design.The Guanine-Nucleotide Exchange Factor Caldag Gefi Fine-Tunes Functional Properties of Regulatory T Cells.Improving transcriptional termination of self-inactivating gamma-retroviral and lentiviral vectors.Eliminating HIV-1 Packaging Sequences from Lentiviral Vector Proviruses Enhances Safety and Expedites Gene Transfer for Gene Therapy.Murine leukemia virus regulates alternative splicing through sequences upstream of the 5' splice site.
P50
Q27313988-7DBE6A92-2C95-4E77-9BCD-C29BFE9C63EAQ28303478-1AC9ED85-16FD-4A53-B767-963077FF3523Q29114083-84ED28EF-0367-4F46-9261-FB65D76C38C5Q33842785-343225E7-22BD-413E-9A45-0867FBB99ECFQ34223822-AC43FCCF-4D8F-4A0E-AF76-8F005223F14BQ35198350-0EDFAE9A-D6B0-49D7-B2FD-61435F0FD31EQ36457016-24F8B54C-3B25-441F-A67E-F75C3A1BA881Q36484018-92F92986-7B3B-4558-9481-C6906BFBBF57Q36841431-D46F9F39-DFC4-4C5F-9F55-B7E84BF6C3F6Q37336436-B4025636-F662-4F15-92E9-D8CE9E8AEB04Q37905103-62812451-2BAA-44E3-AFDA-515610035B15Q38709200-341CADAD-4831-4AED-9063-18BA43D5BAECQ38751544-75C5135E-403A-479C-B936-686B27B9F259Q38885624-D42EDD02-1D33-422B-B446-A8C8C6CA9CCBQ39214743-D04B34E9-2A76-4269-BB7C-D1BC11896165Q39456030-E32B133F-9534-4478-A6F4-9BC85CA7259AQ39488638-C9807BED-B092-46E6-B5E6-A965E4AFEBD8Q39658146-49700DD3-C819-4BE5-BD07-9A0A3BCB0AF6Q39712155-8146CB3E-9EF2-4472-B934-B9012653EA4FQ40142271-711F3D2B-CF13-45A5-82D5-3E43D700A8D2Q40150079-9B726C96-BB59-482D-AE1B-A3B7AE689434Q40183063-FBFC4658-E259-4276-BD5A-5078F2CFDB06Q40220650-870A0912-178C-4FF3-B172-46B3E6DCDFB7
P50
description
onderzoeker
@nl
name
Melanie Galla
@ast
Melanie Galla
@en
Melanie Galla
@es
Melanie Galla
@nl
Melanie Galla
@sl
type
label
Melanie Galla
@ast
Melanie Galla
@en
Melanie Galla
@es
Melanie Galla
@nl
Melanie Galla
@sl
prefLabel
Melanie Galla
@ast
Melanie Galla
@en
Melanie Galla
@es
Melanie Galla
@nl
Melanie Galla
@sl
P214
P106
P21
P213
0000 0000 6487 4816
P214
P31
P735
P7859
viaf-90804903